Suppr超能文献

人类丝氨酸蛋白酶抑制剂-9在生理温度下会自我缔合。

The human serpin proteinase inhibitor-9 self-associates at physiological temperatures.

作者信息

Benning Lauren N, Whisstock James C, Sun Jiuru, Bird Phillip I, Bottomley Stephen P

机构信息

Department of Biochemistry and Molecular Biology, Monash University, P.O. Box 13D, Clayton, Victoria 3800, Australia.

出版信息

Protein Sci. 2004 Jul;13(7):1859-64. doi: 10.1110/ps.04715304.

Abstract

The metastable serpin architecture is perturbed by extremes of temperature, pH, or changes in primary sequence resulting in the formation of inactive, polymeric conformations. Polymerization of a number of human serpins in vivo leads to diseases such as emphysema, thrombosis, and dementia, and in these cases mutations are present within the gene encoding the aggregating protein. Here we show that aggregation of the human serpin, proteinase inhibitor-9 (PI-9), occurs under physiological conditions, and forms aggregates that are morphologically distinct from previously characterized serpin polymers. Incubation of monomeric PI-9 at 37 degrees C leads to the rapid formation of aggregated PI-9. Using a variety of spectroscopic methods we analyzed the nature of the structures formed after incubation at 37 degrees C. Electron microscopy showed that PI-9 forms ordered circular and elongated-type aggregates, which also bind the fluorescent dye Thioflavin T. Our data show that in vitro wild-type PI-9 forms aggregates at physiological temperatures. The biological implications of PI-9 aggregates at physiological temperatures are discussed.

摘要

亚稳态丝氨酸蛋白酶抑制剂结构会受到极端温度、pH值或一级序列变化的干扰,从而导致形成无活性的聚合构象。多种人类丝氨酸蛋白酶抑制剂在体内发生聚合会引发诸如肺气肿、血栓形成和痴呆等疾病,在这些情况下,编码聚集蛋白的基因中存在突变。在此我们表明,人类丝氨酸蛋白酶抑制剂蛋白酶抑制剂-9(PI-9)在生理条件下会发生聚集,并形成形态上不同于先前已表征的丝氨酸蛋白酶抑制剂聚合物的聚集体。将单体PI-9在37℃孵育会导致聚集的PI-9迅速形成。我们使用多种光谱方法分析了在37℃孵育后形成的结构的性质。电子显微镜显示PI-9形成有序的圆形和细长型聚集体,这些聚集体也能结合荧光染料硫黄素T。我们的数据表明,体外野生型PI-9在生理温度下会形成聚集体。文中讨论了PI-9聚集体在生理温度下的生物学意义。

相似文献

2
Serpin crystal structure and serpin polymer structure.
Arch Biochem Biophys. 2006 Sep 1;453(1):123-9. doi: 10.1016/j.abb.2006.03.006. Epub 2006 Mar 23.
4
Molecular gymnastics: serpin structure, folding and misfolding.分子体操:丝氨酸蛋白酶抑制剂的结构、折叠与错误折叠
Curr Opin Struct Biol. 2006 Dec;16(6):761-8. doi: 10.1016/j.sbi.2006.10.005. Epub 2006 Oct 31.
6
Refolding and polymerization pathways of neuroserpin.神经丝氨酸蛋白酶抑制剂的重折叠和聚合途径。
J Mol Biol. 2010 Nov 12;403(5):751-62. doi: 10.1016/j.jmb.2010.07.047. Epub 2010 Aug 4.
9
Human neuroserpin: structure and time-dependent inhibition.人神经丝氨酸蛋白酶抑制剂:结构与时间依赖性抑制
J Mol Biol. 2009 Apr 24;388(1):109-21. doi: 10.1016/j.jmb.2009.02.056. Epub 2009 Mar 2.

本文引用的文献

2
Physical characterization of serpin conformations.
Methods. 2004 Feb;32(2):150-8. doi: 10.1016/s1046-2023(03)00206-8.
4
How do proteins avoid becoming too stable? Biophysical studies into metastable proteins.
Eur Biophys J. 2004 Apr;33(2):83-8. doi: 10.1007/s00249-003-0356-1. Epub 2003 Sep 19.
6
SCREENING FOR AMYLOID WITH THE THIOFLAVIN-T FLUORESCENT METHOD.
Am J Clin Pathol. 1965 Jul;44:59-61. doi: 10.1093/ajcp/44.1.59.
8
A novel mode of polymerization of alpha1-proteinase inhibitor.
J Biol Chem. 2003 May 30;278(22):19611-8. doi: 10.1074/jbc.M210720200. Epub 2003 Mar 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验